436 related articles for article (PubMed ID: 24899058)
21. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
22. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
23. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
24. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
[TBL] [Abstract][Full Text] [Related]
25. Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu.
Kumar V; Ayasolla K; Jha A; Mishra A; Vashistha H; Lan X; Qayyum M; Chinnapaka S; Purohit R; Mikulak J; Saleem MA; Malhotra A; Skorecki K; Singhal PC
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C209-C225. PubMed ID: 31116585
[TBL] [Abstract][Full Text] [Related]
26. In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
Anderson BR; Howell DN; Soldano K; Garrett ME; Katsanis N; Telen MJ; Davis EE; Ashley-Koch AE
PLoS Genet; 2015 Jul; 11(7):e1005349. PubMed ID: 26147622
[TBL] [Abstract][Full Text] [Related]
27. Glomerular Effects of Age and APOL1.
Meyer TW; Lenihan CR
J Am Soc Nephrol; 2015 Dec; 26(12):2901-3. PubMed ID: 26038527
[No Abstract] [Full Text] [Related]
28. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
[TBL] [Abstract][Full Text] [Related]
29. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
Olabisi OA; Zhang JY; VerPlank L; Zahler N; DiBartolo S; Heneghan JF; Schlöndorff JS; Suh JH; Yan P; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):830-7. PubMed ID: 26699492
[TBL] [Abstract][Full Text] [Related]
30. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes.
Scales SJ; Gupta N; De Mazière AM; Posthuma G; Chiu CP; Pierce AA; Hötzel K; Tao J; Foreman O; Koukos G; Oltrabella F; Klumperman J; Lin W; Peterson AS
J Am Soc Nephrol; 2020 Sep; 31(9):2044-2064. PubMed ID: 32764142
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.
Gupta N; Waas B; Austin D; De Mazière AM; Kujala P; Stockwell AD; Li T; Yaspan BL; Klumperman J; Scales SJ
Sci Rep; 2024 Feb; 14(1):3765. PubMed ID: 38355600
[TBL] [Abstract][Full Text] [Related]
33. APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes.
Kruzel-Davila E; Shemer R; Ofir A; Bavli-Kertselli I; Darlyuk-Saadon I; Oren-Giladi P; Wasser WG; Magen D; Zaknoun E; Schuldiner M; Salzberg A; Kornitzer D; Marelja Z; Simons M; Skorecki K
J Am Soc Nephrol; 2017 Apr; 28(4):1117-1130. PubMed ID: 27864431
[No Abstract] [Full Text] [Related]
34. APOL1 kidney risk alleles: population genetics and disease associations.
Limou S; Nelson GW; Kopp JB; Winkler CA
Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
[TBL] [Abstract][Full Text] [Related]
35. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
Ma L; Shelness GS; Snipes JA; Murea M; Antinozzi PA; Cheng D; Saleem MA; Satchell SC; Banas B; Mathieson PW; Kretzler M; Hemal AK; Rudel LL; Petrovic S; Weckerle A; Pollak MR; Ross MD; Parks JS; Freedman BI
J Am Soc Nephrol; 2015 Feb; 26(2):339-48. PubMed ID: 25012173
[TBL] [Abstract][Full Text] [Related]
36. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
Kormann R; Jannot AS; Narjoz C; Ribeil JA; Manceau S; Delville M; Joste V; Prié D; Pouchot J; Thervet E; Courbebaisse M; Arlet JB
Br J Haematol; 2017 Oct; 179(2):323-335. PubMed ID: 28699644
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
[TBL] [Abstract][Full Text] [Related]
38. APOL1 and kidney disease.
Pollak MR; Genovese G; Friedman DJ
Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
[TBL] [Abstract][Full Text] [Related]
39. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
40. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
